Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
10/2006
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006US20060226421 Amine compound and uses thereof
10/12/2006DE102005013258B3 Verfahren zur Herstellung von Naringeninderivaten aus Xanthohumol A process for preparing Naringeninderivaten from xanthohumol
10/11/2006EP1710240A1 Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
10/11/2006EP1710239A1 Process for producing chroman compound
10/11/2006EP1709022A1 Selective estrogen receptor modulators
10/11/2006EP1709021A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
10/11/2006EP1181013B1 Method and composition for the treatment of cancer
10/11/2006CN1844117A Method for removing micro polynary arene in natural vitamine E
10/11/2006CN1844116A Extraction separation purification and identification of flavonoid monomers in oriental blueberry melanin
10/11/2006CN1844115A Process for preparing tectori-genin
10/11/2006CN1843418A Traditional Chinese medicine extract for treating gastroenteritis and traditional Chinese medicine composition containing same
10/11/2006CN1279052C Process for extracting total flavone and total oside of astragalus from astragalus
10/11/2006CN1279036C Substituted benzopyran derivatives against arrhythmia
10/11/2006CN1279035C Method for synthesizing optical enantiomer 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid and 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylate
10/11/2006CN1279034C Dna-pk抑制剂 Dna-pk inhibitors
10/11/2006CN1279010C Method for preparing tea polyphenol in high-efficiency
10/10/2006US7119212 Process for the preparation of tolterodine and intermediates thereof
10/10/2006US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/10/2006CA2359046C Heterocyclically anellated indenochromene derivatives
10/10/2006CA2231292C Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
10/06/2006CA2560740A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
10/05/2006WO2006103527A1 Aromatic substituted pentadienoic acid amide for combination with anti-infective drugs
10/05/2006WO2006102958A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
10/05/2006WO2006102789A1 Ferula fukanensis extract, the preperation method and the use in producing medicine thereof
10/05/2006US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/05/2006US20060223879 Non-steroidal farnesoid x receptor modulators
10/05/2006US20060223828 Substituted chroman derivatives
10/05/2006US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid
10/05/2006CA2601126A1 Substituted aminoalkyl- and amidoalkyl-benzopyran derivatives
10/05/2006CA2600833A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
10/04/2006EP1707610A2 Photochromic polymerizable composition
10/04/2006EP1706110A1 Therapeutic use of quinonoid derivatives of cannabinoids
10/04/2006EP1545206A4 Compositions and products containing enantiomeric equol, and methods for their making
10/04/2006EP1507527A4 Methods for enhancing motor performance and/or endurance
10/04/2006CN1842580A Photochromic compounds
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/04/2006CN1277827C High-purity tea polyphenols extraction method
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115745 Benzyl urea and thiourea derivatives
10/03/2006US7115661 Methods and compositions for mitigating pain
10/03/2006US7115657 Blocking free radical scavenger from lipid membranes; therapy for cardiovascular disorders
10/03/2006US7115656 Administering cocoa extracts including procyanidin monomers and oligomers to treat inflammation, atherosclerosis, and cardiovascular disorders; bactericides, foods; cyclooxygenase and/or lipoxygenase inhibitors
10/03/2006US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential
10/03/2006CA2151507C Pharmaceutical composition containing bicyclic type compounds
09/2006
09/28/2006WO2006100710A1 Preventive or therapeutic composition for severe acute respiratory syndrome
09/28/2006WO2006100468A1 Treatment of laminitis
09/28/2006WO2006099914A1 Method for producing naringenin derivatives from xanthohumol
09/28/2006US20060217565 Process for producing chromone compound
09/28/2006US20060217564 Production of isoflavone derivatives
09/27/2006EP1704139A1 DISUBSTITUTED CHALCONE OXIMES AS SELECTIVE AGONISTS OF RAR y RETINOID RECEPTORS
09/27/2006CN1839125A (3R,4R)-trans-3,4-diarylchroman derivatives with estrogenic activity
09/27/2006CN1837202A Flavonols with blood-fat-lowering effect
09/27/2006CN1837201A Process for extracting tea polyphenol, theanine, tea polysaccharide and tea pigment from tea
09/27/2006CN1837169A Compound capable of inhibiting zinc ion metalloproteinases
09/26/2006US7112684 fluorescent dye-fused lactone derivative covalently attaches to biological agent; xanthene or phenoxazine derivatives; chroman-2-one dyes
09/26/2006CA2288122C Neuropeptide y receptor antagonist
09/21/2006WO2006097811A1 Method for converting aloeresin a to aloesin
09/21/2006US20060211675 Preventives/remedies for urinary disturbance
09/21/2006US20060211635 total pomegranate tannins (TPT) including punicalagin; nutraceutical for cardiovascular health
09/21/2006DE102005011534A1 Chromen-4-on-Derivate Chromen-4-one derivatives
09/21/2006CA2600797A1 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
09/20/2006EP1701946A2 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
09/20/2006EP1509491B1 Intermediate products, methods for their preparation and use thereof
09/20/2006EP1438337B1 Crystals of cytochrome p450 2c9, structures thereof and their use
09/20/2006EP0889889B1 Piperazine and piperidine compounds
09/20/2006CN1835940A Chromen-4-one derivatives
09/20/2006CN1834097A Method of producing 10-hydroxy camptothein
09/20/2006CN1834093A Synthetic process of chiral 2-amido-1-(6-fluorine-3,4-dihydrobenzopyranyl) alCohol
09/20/2006CN1276088C Method for purifying raw anthocyanidin oligomer
09/20/2006CN1275969C Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method
09/20/2006CN1275958C Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use
09/20/2006CN1275957C Method for preparing common smoketree extract
09/20/2006CN1275956C Process for preparing scutellarin from baicalin
09/20/2006CN1275955C Process for extracting total skullcapflavone aglycone
09/19/2006US7109358 Process for the preparation of isoflavones
09/19/2006US7109327 Oxidizing agent mixed with a support starting from 8-methoxy-3,4,4a,8a-tetrahydro-spiro-chromen-2-one-[4,4']-cyclohex-2',5'-dien-1'-one to a spirodienone yields 1.6 (+-)-11-oxonarwedine or (+-)-6-methoxy-10-methyl-galantham-1-ene-3,11-dione; treating Alzheimer's disease
09/19/2006US7109236 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
09/19/2006US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors
09/19/2006US7109043 Fluorescent probe for magnesium ion determination
09/19/2006US7108871 Isoflavones and saponins in defined ratios, menopause, cancer
09/14/2006WO2006095864A1 Anti-inflammatory agent
09/14/2006WO2006095263A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
09/14/2006WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/14/2006WO2006094601A1 Chromen-4-one derivatives
09/14/2006WO2006094357A1 Flavonoid compounds and uses thereof
09/14/2006US20060205959 Process for performing an isolated Pd(II)-mediated oxidation reaction
09/14/2006US20060205807 Amino-chroman compounds and methods for preparing same
09/14/2006US20060204990 Compounds and methods for fluorescent labeling
09/14/2006DE19922287B4 Verwendung von Flavonoidestern in Kosmetika Use of Flavonoidestern in cosmetics
09/14/2006CA2601028A1 Flavonoid compounds and uses thereof
09/14/2006CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors
09/13/2006EP1699775A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
09/13/2006EP1401962B1 Method for increasing hydrophilicity of fluorescent label compounds
09/13/2006CN1832942A Novel process for the preparation of 2h-chromenes
09/13/2006CN1830993A Method for producing mixture of phytosterol and vitamin E
09/13/2006CN1830973A 9-anthrone lactone compounds, preparing method and use thereof
09/13/2006CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain
09/13/2006CN1274684C Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 242